Brighton Jones LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
+5,987
| New | +$230K | 0.01% | 818 |
|
|
2025
Q1 | – | Sell |
-15,604
| Closed | -$528K | – | 719 |
|
|
2024
Q4 | $528K | Buy |
+15,604
| New | +$528K | 0.02% | 375 |
|
|
2024
Q3 | – | Sell |
-6,999
| Closed | -$269K | – | 617 |
|
|
2024
Q2 | $269K | Sell |
6,999
-6,137
| -47% | -$236K | 0.01% | 498 |
|
|
2024
Q1 | $563K | Buy |
+13,136
| New | +$563K | 0.02% | 325 |
|
|
2014
Q3 | – | Sell |
-4,179
| Closed | -$279K | – | 210 |
|
|
2014
Q2 | $279K | Sell |
4,179
-634
| -13% | -$42.3K | 0.06% | 145 |
|
|
2014
Q1 | $321K | Sell |
4,813
-442
| -8% | -$29.5K | 0.08% | 127 |
|
|
2013
Q4 | $351K | Buy |
+5,255
| New | +$351K | 0.08% | 121 |
|